Hortonworks and Revolution Analytics provide massive-scale data handling
Integrichain (Princeton, NJ), which has been one of a handful of developers of analytics services based on, among other things, commercial EDI data from pharma trading partners, is upgrading its offerings based on alliances with a pair of Big Data developers: Hortonworks (Palo Alto, CA) and Revolution Analytics (Mountain View, CA). Hortonworks, in turn, is a developer of “open source enterprise Apache Hadoop software,” and Revolution Analytics is a developer of the R programming language, which it characterizes as “the single most important tool for computational statistics, visualization and data science.”
Josh Halpern, Integrichain co-founder and EVP, provides a translation: “These IT resources are comparable to what the major Internet-based e-commerce companies, like Amazon or Facebook, use to manage their systems or mine data to find trends. In the context of pharma distribution agreements, we’re seeing instances where a pharma company wants to analyze thousands of SKUs [stockkeeping units] across thousands of customers, over a multi-year span. You can do that with existing tools, but handling massive data loads like that are becoming more and more difficult without these cutting-edge IT tools.”
In practice, Integrichain will be incorporating these IT capabilities into its Demand Networks Analytics (DNA) platform, which is used by many major pharma companies to analyze trade agreements, market trends and the like. Some new service offerings will be rolled out over the next several months, says Halpern.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.